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ABSTRACT
Melissococcus plutonius is a bacterial pathogen that causes epidemic outbreaks of European
foulbrood (EFB) in honey bee populations. The pathogenicity of a bacterium depends on its
virulence, and understanding the mechanisms influencing virulence may allow for improved
disease control and containment. Using a standardized in vitro assay, we demonstrate that
virulence varies greatly among sixteen M. plutonius isolates from five European countries.
Additionally, we explore the causes of this variation. In this study, virulence was independent of
the multilocus sequence type of the tested pathogen, and was not affected by experimental co-
infection with Paenibacillus alvei, a bacterium often associated with EFB outbreaks. Virulence
in vitro was correlated with the growth dynamics of M. plutonius isolates in artificial medium,
and with the presence of a plasmid carrying a gene coding for the putative toxin melissotoxin
A. Our results suggest that some M. plutonius strains showed an increased virulence due to the
acquisition of a toxin-carrying mobile genetic element. We discuss whether strains with increased
virulence play a role in recent EFB outbreaks.
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Introduction
The Western honey bee (Apis mellifera L.) is an insect
of major worldwide ecological and economic impor-
tance. Honey bees produce honey and wax and polli-
nate many economically important crops[1]. The recent
loss of managed honey bee colonies in several regions
of the world threatens the ecological services provided
by this pollinator [2–5]. Consequently, honey bee
health has become a major concern not only for scien-
tists, but also for the public and policy-makers [6–8].
Current research indicates that pathogens are a major
cause of colony losses. Honey bee pathogens include
viruses [9], protozoa [10], fungi [11], parasitic mites
[12] and bacteria [7,9,13,14]. One of the most detri-
mental bacterial diseases affecting honey bees is
European foulbrood (EFB). EFB is reported worldwide
[15] and has emerged as an infectious disease since the
mid-eighties in the United Kingdom, since the year
2000 in Switzerland and since 2010 in Norway
[13,14,16,17]. High numbers of clinical cases have also
been reported from Finland, France, Greece, Holland,
Czechia and Italy [18–20], making EFB an economic-
ally important veterinary disease [18,21].
The pathogenic agent of EFB, Melissococcus pluto-
nius (Lactobacillales, Enterococcaceae) [22], enters the
intestinal tract of honey bee larvae through contami-
nated food provided by adult bees [23]. Once ingested,
M. plutonius rapidly multiplies in the mid-gut lumen,
possibly depriving the host of nutrients [24]. Diseased
larvae typically change from white to a yellowish color,
become flaccid and die 4–5 days after infection [23,25].
The massive loss of brood resulting from severe infec-
tion weakens the colony and can lead to its col-
lapse [25].
To date, only broad-spectrum antibiotics such as
oxytetracycline are available to treat EFB-affected colo-
nies. Due to the risk of antibiotic resistance develop-
ment [26,27] and an accumulation of residue in honey,
the use of antibiotics is not a sustainable method to
control EFB and is banned in some countries. In the
absence of efficient treatment and given the severity of
EFB outbreaks, 79 countries worldwide have classified
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EFB as a notifiable disease (World Animal Health
Information Database, OIE [28]). In 22 of these coun-
tries, veterinary authorities destroy symptomatic colo-
nies and monitor neighboring apiaries to avoid the
further spread of the pathogen, which is costly and
time-consuming. This situation calls for new control
strategies, but their development is constrained by the
limited knowledge of the pathogenesis of EFB [23].
Virulence is central to pathogenesis. A better knowl-
edge of the mechanisms that determine this trait could
contribute to the design of improved control methods.
Indeed, virulence factors are promising targets for specific
drugs or management measures [29]. Such measures
include curing honey bee colonies hosting less virulent
pathogens and restricting the use of destructive control
methods to treat infections caused by more virulent
pathogens [30]. An assessment of the extent and causes
of virulence variation in strains of M. plutonius may thus
prove useful in controlling EFB more efficient and more
sustainable to improve honey bee health.
Early reports [31,32] suggested that M. plutonius
isolates were genotypically and phenotypically homo-
geneous. As a result, variation in virulence was not
expected. The discovery of genetic differences between
isolates [33–40] has challenged this view. Differences in
virulence have indeed been documented within
M. plutonius, with strains defined as atypical by Arai
et al.,2012 [34], killing a higher proportion of hosts in
a shorter time period than typical strains. Differences in
virulence also occur between typical strains, depending
on experimental conditions [41,42]. However, no viru-
lence factor has yet been clearly identified.
Several factors are likely to influence the virulence of
pathogens. One is the impact of secondary agents [43].
In the case of EFB, saprophytic species such as
Paenibacillus alvei, Enterococcus faecalis, Brevibacillus
laterosporus or Achromobacter eurydice cause secondary
bacterial infections that might increase damage to larvae
[23,44]. However, their influence in EFB is debated
[42,45–47]. Another potential cause of variation in viru-
lence is the growth dynamics of the bacterial pathogen.
Bacterial strains that multiply rapidly and reach high
densities can cause more damage to the host [48,49].
Other major factors influencing virulence include the
production of biologically active compounds, such as
adhesins improving attachment to host cells, enzymes
degrading host tissues, or toxins disturbing the physio-
logical processes of the host [50–55].
Experiments aimed at quantifying the virulence of
M. plutonius and identifying factors that influence viru-
lence have been hampered by the complex social envir-
onment of the honey bee colony that affects the spread
and growth of the bacteria [56,57], and by the legal
obligation to destroy colonies showing disease symp-
toms [14]. These constraints can be overcome by
experimentally infecting honey bee larvae reared
in vitro. In the past, such assays were considered
impossible due to M. plutonius loss of infectivity during
bacterial sub-cultivation [46,56,58]. More recently, sev-
eral studies using the in vitro larval rearing method [59]
have circumvented this problem [34,41,42,47,60–62],
making standardized quantification of virulence possi-
ble without any sanitary risk to the colonies in the field.
In this study, we reared honey bee larvae in vitro and
infected them with M. plutonius to investigate the causes
and extent of variation in virulence. We screened
17 M. plutonius isolates collected from five European
countries for genetic differences and measured their viru-
lence over the entire developmental period of worker
brood. We examined whether virulence was associated
with M. plutonius multilocus sequence type (MLST), co-
infection with P. alvei, differences in growth dynamics in
a culture medium and presence of a putative toxin-coding
gene [39]. We discuss whether M. plutonius strains with
high virulence play a role in recent EFB outbreaks and
whether they could be targets for more sustainable control
measures of the disease.
Results
Virulence of M. plutonius strains
The M. plutonius isolates collected in various regions of
Europe belonged to six multilocus sequence types and
two clonal complexes (CC 3 and CC 13, Table 1) of the
typical form. After excluding cases with excessive con-
trol mortality, we obtained enough replicates to quan-
tify the virulence of 16 out of the 17 isolates tested. The
virulence of these isolates in terms of honey bee brood
mortality in vitro varied greatly (Figure 1). Three Swiss
isolates (CH 21.1, CH 49.3 and CH 60) were highly
virulent, causing over 80% mortality in infected brood
up to the imago stage (Table 1, Table. S2, Figure. S3).
These isolates caused significant mortality compared to
the controls (Figure 1; pairwise log-rank tests,
Bonferroni-Holm corrected, p < 0.001, Table. S1,
Figure. S3). Eight isolates (FR 27.1, CH 119, CH 54.1,
CH 46.1, CH 45.1, CH 40.2, NO 764–5B, NO 765–6B)
had low to intermediate virulence, causing a brood
mortality of 15 to 55%, which was significantly higher
than that of the controls (Figure 1; pairwise log-rank
tests, Bonferroni-Holm corrected, p < 0.001, Table. S1
and S2, Figure. S3). The mortality of the brood infected
with each of the remaining five isolates (UK 36.1, UK
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Figure 1. Survival of in vitro reared honey bee brood infected with 16 M. plutonius isolates (isolate code indicated in each panel).
Grey, blue and red curves correspond to avirulent, low to intermediate and high virulence isolates, respectively. The black curve
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31.1, CH MeplS1, CH 82, IT 1.3) was not significantly
higher than that of the non-infected control brood.
These isolates were therefore categorized as avirulent
(Figure 1; pairwise log-rank tests, Bonferroni-Holm
corrected, n.s., Table. S1 and S2, Figure. S3).
Mortality caused by M. plutonius, P. alvei and
co-infection
The survival of the honey bee brood after a single
infection with M. plutonius CH 90 (Mean Henderson-
Tilton corrected mortality 22.6%, Tab. S2) was signifi-
cantly lower than the survival of the non-infected con-
trol brood (Figure 2, Table. S4; pairwise log-rank tests,
Bonferroni-Holm corrected p = 0.006). Single infection
with P. alvei DSM29 (Mean Henderson-Tilton cor-
rected mortality 8.8%, Tab. S2) also caused significant
mortality within the brood (Figure 2, Table. S4; pair-
wise log-rank tests, Bonferroni-Holm corrected
p = 0.007), as did co-infection with M. plutonius CH
90 and P. alvei DSM29 (Figure 2, Table. S2 and S4;
pairwise log-rank tests, Bonferroni-Holm corrected
p = 0.004; Mean Henderson-Tilton corrected mortality
23.1%). However, no significant increase in mortality
was observed after co-infection with M. plutonius and
P. alvei compared to single infections with one bacterial
species alone (Figure 2 Tab. S4, pairwise log-rank tests,
Bonferroni-Holm corrected p > 0.01).
Growth dynamics and virulence of M. plutonius
The M. plutonius isolates varied in their in vitro growth
dynamics (Figure 3). Some bacterial isolates multiplied
rapidly to high cell densities, while others multiplied
slowly and reached low final cell densities in liquid
basal medium at the end of the observation period.
Other strains showed mixed features, multiplying
rapidly to low final cell densities and inversely. Four
isolates of low to intermediate virulence (FR 27.1, CH
45.1, NO 764–5B and NO 765–6B) and one avirulent
indicates survival of non-infected controls. N = number of larvae tested. Dashed lines represent 95% confidence intervals. Significant
differences in the survival of brood due to treatments (uncorrected for control mortality) are indicated by different letters (pairwise
log-rank tests, Bonferroni-Holm corrected, p < 0.001).
Figure 2. Survival of in vitro reared honey bees exposed to M. plutonius isolate CH 90, orange curve) or to P. alvei reference strain
DSM29 (purple curve) only, or after co-infection with M. plutonius CH 90 and P. alvei DSM29 (green curve). The black curve indicates
the survival of non-infected controls. Dashed lines represent 95% confidence intervals and N designates the number of larvae tested.
Significant differences in the survival of brood due to treatments are indicated by different letters (pairwise log-rank tests,
Bonferroni-Holm corrected, p < 0.01).
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isolate (IT 1.3) showed no significantly different growth
pattern as isolates of high virulence (CH 49.3, CH 60
and CH 21.1; Figure 3, Tables. S5 and S6). OD600 of
most isolates decreased abruptly after 84 h, indicating
bacterial mortality. We thus considered this time point
as indicative of final density reached. Four isolates of
low to intermediate virulence (FR 27.1, CH 45.1, NO
764–5B and NO 765–6B) reached final densities as high
as those measured in high virulence isolates (CH 49.3,
CH 21.1 and CH 60; Figure 3, Table. S5). M. plutonius
isolates causing over 40% mortality (corrected through
a Henderson-Tilton calculation) in the in vitro larval
infection assay, also reached high final densities in basal
medium with OD600 values at 0.7 or above, and five out
of the seven most virulent isolates reached OD600
values above 0.8 (Tab. S5).
Presence of melissotoxin A gene
The three highly virulent M. plutonius isolates CH 21.1,
CH 49.3 and CH 60 were positive for the gene encoding
melissotoxin A in PCR screening, while all other iso-
lates were negative (Table 1, S8).
Relative contribution of sequence type, clonal
complex, growth rate, final cell density and
melissotoxin A to the virulence of M. plutonius
The multiple regression model, including sequence
type, clonal complex, generation time, final cell densi-
ties and the presence of melissotoxin A gene, explained
a significant part of brood mortality (R2 = 0.806, F5,15
= 7.483, p < 0.005; Tab S7). While the presence of the
plasmid detected through the amplification of a 1.36
kbp-fragment of a putative toxin gene significantly
predicted brood mortality (B = 45.802, β = 0.617,
p < 0.007), neither sequence type (B = 0.757,
β = 0.270, p = 0.422), nor clonal complex
(B = −2.419, β = −0.384, p = 0.277), nor generation
time (B = −2.952, β = −0.068, p = 0.671), nor cell
density reached at 84 h (B = 74.226, β = 0.342,
p = 0.068) was significantly associated with brood mor-
tality. The model did not show any correlation between
the mortality rate induced in the honey bee brood
(N = 15, Kendall’s τ = 0.175, p = 0.266; Tab. S7) and
the generation time of the tested M. plutonius isolates
during their exponential growth phase in artificial med-
ium, which ranged from 3 to 6 h (Table 1). In contrast,
final cell density (at 84 h) was positively and signifi-
cantly correlated with mortality (N = 15, Kendall’s
τ = 0.641, p < 0.005, Tab. S7).
Discussion
Virulence varies among M. plutonius isolates
Mortality of the honey bee brood caused by the
M. plutonius isolates tested varied greatly. The variation
in virulence among the 16 isolates was independent of
their multi-locus sequence type and clonal complex
affiliation. Variation in virulence among strains of the
so called “atypical” M. plutonius belonging to different
clonal complexes has recently been documented [41].
Our results indicate that variation in virulence also
Figure 3. Growth curves of 17 M. plutonius isolates in artificial medium. Red, blue and gray curves correspond to high, low-
intermediate virulence and avirulent isolates, respectively. See Tab. S5 for mean OD600-values and SD and table S6 for statistical
differences in growth dynamics between isolates.
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occurs in clonal complexes belonging to the “typical”
strains of M. plutonius as observed in [42]. Mortality
rates also varied among replicates of in vitro infection
tests using the same M. plutonius isolate, but larvae of
different colonies. This is in line with the results from
two recent studies [41,42] and may be due to variation
in host susceptibility. Although all but one isolate (CH
MeplS1) tested in this study came from honey bee
colonies with explicit symptoms of an acute EFB infec-
tion, four isolates (UK 36.1, UK 31.1, CH 82 and IT
1.3) did not cause elevated larval mortality in vitro, and
were therefore ranked as avirulent. It is possible that
this discrepancy is a methodological artifact due to the
loss of the plasmid carrying the putative virulence fac-
tor during cultivation on artificial media. Although the
tested isolates were subjected to the same laboratory
procedures, random loss of the plasmid cannot be
excluded. Alternatively, negative effects on the develop-
ment or physiology of the larvae not detected in our
assay could have triggered increased removal by adult
hygienic workers, generating the typical spotty brood
pattern in EFB-diseased colonies. It is also possible that
bacterial isolates less virulent at individual level are
highly virulent at colony level, and vice versa, as was
hypothesized for Paenibacillus larvae [63]. Larvae
infected with low virulence isolates might be removed
slower than larvae affected by high virulence isolates.
A low removal rate could facilitate the production and
spread of the pathogenic bacteria within the colony. It
is highly likely that the in vivo virulence of M. plutonius
at colony level is modulated by the effect of the social
immunity of the colony [64], as proposed for P. larvae
[63,65] and be different from virulence quantified
in vitro.
No evidence that co-infection with P. alvei
increases mortality
Our results indicate that the presence of the secondary
agent P. alvei is not required to induce brood mortality.
We observed high larval mortality after single infection
with some of the M. plutonius isolates, in line with
former studies [34,41,42,62]. To our knowledge, this is
the first report on single infections with P. alvei in an
in vitro infection assay. In this study, single infection
with P. alvei strain DSM29 caused significant mortality
to the honey bee brood. In contrast, co-infection with
M. plutonius did not increase brood mortality beyond
the effect of single infections with the tested
M. plutonius isolate (CH 90). These results are similar
to those of Lewkowski and Erler, 2018 [42], but differ
from those of Giersch et al., 2010 [47], probably
because of methodological differences (e.g., different
infection time, higher concentration of P. alvei used
in their study). To better understand the role of sec-
ondary agents, other bacteria associated with EFB
should be tested singly and in co-infections with
a larger set of M. plutonius isolates in vitro [42] as
well as in vivo in honey bee colonies.
Relationship between M. plutonius growth
dynamics and virulence
The growth dynamics of M. plutonius isolates in the
culture medium were highly variable. The bacterial
generation time in the artificial medium did not predict
mortality in the honey bee brood. The final bacterial
density may play a more important role in determining
pathogenicity (sensu [66]) than the generation time. All
isolates defined as being of intermediate or high viru-
lence reached high final densities in the culture med-
ium, and isolates with lower final densities caused low
mortality. This pattern obtained in vitro suggests that
strains must reach a damage threshold to induce high
mortality. Although the growth dynamics of
M. plutonius isolates in culture medium as observed
in this study may be different from that in honey bee
larvae, the hypothesis that a high bacterial load is
a prerequisite for high virulence is supported by the
occurrence of a positive correlation between bacterial
numbers and virulence in vivo [41,62]. However, some
low virulence isolates reached high final densities in the
culture medium at 84 h, suggesting that factors other
than the number of M. plutonius bacteria are involved
in causing high mortality in honey bee brood.
Role of melissotoxin A in virulence
The melissotoxin A gene was restricted to three highly
virulent Swiss isolates (CH 21.1, CH 49.3 and CH 60)
and the presence of this gene was a significant predictor
of honey bee brood mortality (Tab. S5). In our experi-
ment, the bacterial isolate CH MeplS1 was avirulent.
This isolate originated from a bacterial culture of the
highly virulent isolate CH 49.3 and lost plasmid pMP19
(19.4 kbp; GenBank: JSBA01000009.1) after repeated
sub-cultivation [39]. Plasmid pMP19 encodes melisso-
toxin A (GenBank: KMT29105) and another putative
virulence factor, the extracellular matrix-binding pro-
tein [39]. While the additional loss of genome-encoded
virulence factors in CH Mepl S1 cannot be excluded,
the simultaneous loss of pMP19 and virulence suggests
a causal link.
A further piece of evidence for the possible implica-
tion of the melissotoxin A gene in virulence is that it is
expressed by M. plutonius during infection in vivo
560 D. GROSSAR ET AL.
[39,62]. This gene shares a high sequence similarity
with the epsilon toxins of the ETX/MTX2 family
(pfam03318 of Clostridium perfringens, 33% amino
acid sequence identity [39] and of Bacillus pumilus
with 48% sequence identity, 90% coverage and an
Expect (E)-value of 7e-73, NCBI query; https://www.
ncbi.nlm.nih.gov/). Epsilon toxins change the cell per-
meability for ions by forming large membrane pores,
causing cell death and edema in animal models [67]. It
was recently suggested that a protein of the ETX/MT2
family is an important virulence factor in two subtypes
of P. larvae, the causative pathogen of American foul-
brood [68]. It is thus plausible that melissotoxin
A increases the virulence of M. plutonius by corrupting
the cells of the larva’s digestive tract.
The melissotoxin A gene is situated on plasmid
pMP19 [39]. Plasmids can easily be exchanged between
individual bacterial cells within and between species
[69]. The plasmid pMP19 found in certain
M. plutonius strains, including atypical isolates from
Japan [40,62], may originate from other bacterial inva-
ders co-existing with M. plutonius in the intestinal tract
of honey bee larvae. The fact that the toxin gene is
located on a mobile genetic element can explain the
absence of association between brood mortality and the
sequence type or clonal complex of the isolates used in
this study.
The conventional explanation for the negative effect
of M. plutonius is a competition for nutrients in the gut
[25]. Although not mutually exclusive, our finding that
a toxin-carrying mobile genetic element could confer
high pathogenicity to certain M. plutonius isolates sug-
gests a direct detrimental effect on gut cells. This mode
of action is in line with the findings of McKee et al.,
2004 [46] and with evidence that M. plutonius still
caused high larval mortality in in vitro experiments
where food was given in excess [34,41,42,46,47,60–62].
Further experiments will be needed to demonstrate
the direct role of melissotoxin A in the pathogenicity of
M. plutonius. Such experiments include producing
genetically modified strains of M. plutonius, for exam-
ple by removing plasmid pMP19 from highly virulent
strains, knocking-out melissotoxin A gene on pMP19
(pMP19Δmelissotoxin A gene), transforming wildtype
pMP19 and pMP19Δmelissotoxin A gene into low viru-
lent isolates of M. plutonius, as well as producing the
putative toxin in the laboratory. The impact of mutant
strains or the synthesized toxin on honey bee larvae
could then be directly tested in vitro. Curing pMP19
from Japanese M. plutonius isolates belonging to CC 3
resulted in a loss of virulence [62], supporting our
hypothesis for the role of the melissotoxin A gene.
However, transformation experiments aimed at
introducing the plasmid back in the cured isolates did
not result in recuperation of virulence [62]. A reduced
growth of these isolates due to the transformation pro-
tocol was provided as an explanation [62], in line with
our suggestion that rapid multiplication is also required
to produce highly virulent phenotypes. The role of the
putative virulence gene on pMP19 could not be con-
firmed in a Japanese isolate of CC 13 [62]. A reduced
growth of this isolate could also explain its low viru-
lence despite the gene’s presence.
Is the recent emergence of EFB due to highly
virulent strains?
The question then arises as to whether the recent emer-
gence of EFB is linked to the occurrence of bacterial
strains of particularly high virulence at the colony level.
Virulence trade-off models predict that the virulence of
a pathogen is inversely correlated to its transmission,
because excessive virulence causes early host death,
hindering the spread of the pathogen amongst the
population [70–73]. However, human-induced changes
in the rate of horizontal transmission may have altered
the adaptive compromise between virulence and trans-
mission in M. plutonius [17,74,75]. Increased contact
between honey bee colonies due to human manage-
ment may allow for the spread of highly virulent strains
unable to spread to new hosts under more natural
settings.
More extensive field screening of the prevalence of
different M. plutonius sequence types and of the plas-
mid carrying the melissotoxin A gene will reveal if
highly virulent strains of M. plutonius arose by acquir-
ing this toxin-carrying mobile genetic element. This
will also contribute to a better understanding of the
origin of recent epidemic outbreaks of EFB. If a link
between virulence and disease outbreaks in the field can
be established, strain-specific, virulence-based control
methods can be promising avenues to better control the
spread of EFB [29,30]. The melissotoxin A gene could
provide a putative marker for such specific control
methods.
Conclusion
Infection with M. plutonius alone caused European
foulbrood symptoms in honey bee brood reared
in vitro. Bee mortality varied substantially among 16
investigated M. plutonius isolates, independently of
their sequence type. Mortality did not increase when
larvae were infected with the potential secondary agent
P. alvei in combination with a M. plutonius isolate of
low to intermediate virulence. Variation in the
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virulence of M. plutonius isolates was not significantly
linked to growth dynamics. A high final density in the
culture medium was reached by highly virulent isolates,
but was not sufficient to explain the high mortality
caused by these M. plutonius isolates. High virulence
was associated with the presence of a plasmid carrying
the putative toxin melissotoxin A, suggesting that this
mobile genetic element is a major factor in the viru-
lence of M. plutonius. These new insights into the
pathogenicity of a poorly understood, but important
honey bee disease may serve as a basis for the develop-
ment of more sustainable control methods.
Experimental Procedures
Origin and culture of M. plutonius isolates
Diseased larvae were collected from European foul-
brood (EFB) outbreaks in several European regions
(Table 1) and sent to our laboratory for the purpose
of M. plutonius isolation. The only exception was the
Norwegian samples, which were processed elsewhere.
Melissococcus plutonius was isolated from smears of
diseased larvae on basal medium. The medium con-
tained 1% yeast extract, 1% glucose, 1% saccharose,
0.04% L-cysteine and 0.1 M KH2PO4 in distilled
water, with a pH adjusted to 6.7 with 5 M KOH. The
medium was solidified with 18 g agar/liter and auto-
claved at 121°C for 18 min [58,76]. After incubation for
four days at 36°C under anaerobic conditions (GENbox
anaer, bioMérieux), individual bacterial colonies iden-
tified as M. plutonius based on colony morphology
were picked from the Petri dishes and inoculated in
a liquid basal medium or on plates. The plates were
incubated anaerobically for another four days at 36°C.
Isolate stock solutions were supplemented with 15%
glycerol and stored at −80°C until further use.
PCR identification of M. plutonius and detection of
the gene encoding melissotoxin A
Isolates were confirmed as M. plutonius by PCR as
described by Govan et al., 1998 [74]. The strains were
further identified as either “typical” or “atypical” fol-
lowing the protocol described in Arai et al., 2014 [77].
The multi-locus sequence type and clonal complex of
each isolate were assessed as described in Haynes et al.,
2013 [36]. We screened for the presence of melissotoxin
A gene (GenBank: KMT29105) [39] using specific pri-
mers (tox_MEPL_for: 5ʹ-GCTCAAGCAGCAACTTTT
ACG-3ʹ and tox_MEPL_rev: 5ʹ-TTCCCCTGGTAT
TACTTGTAGATG-3ʹ; fragment size approx. 1.36
kbp) in a conventional PCR reaction using KAPA2 G
Fast DNA Polymerase (KAPA Biosystems). DNA was
extracted with the NucleoSpin Tissue kit from
Macherey-Nagel according to the manufacturer’s
instructions, the DNA-concentration was measured
with NanoDrop® ND-1000 spectrophotometer
(NanoDrop, Thermo Fischer Scientific, USA) and
each DNA-extract diluted to 5 ng DNA per µl. Each
reaction in the PCR consisted of 2 µl template DNA-
extract, 13 µl KAPA2 G fast ready mix (2x), 1 µl for-
ward primer (10 µM), 1 µl reverse primer (10 µM), and
8 µl water added to a total reaction volume of 25 µl.
The PCR started with an initial denaturation step at 95°
C for 3 min, followed by 40 cycles of denaturation at
95°C for 15 s, annealing at 58°C for 15 s and DNA
extension at 72°C for 20 s, and a final extension step at
72°C for 2 min (TProfessional Basic Thermocycler,
Biometra). PCR products were visualized under UV
light after staining the 1.5% agarose gel with GelRed™
(Biotium).
Infection assays of honey bee larvae reared
in vitro
Honey bee brood originating from healthy, queenright
colonies was used in the infection assays. Same aged
larvae were obtained by confining queens to empty
combs for the purpose of egg-laying, using excluder
cages. After 36 hours, the queens were removed from
the cages for three days, until first instar larvae hatched.
First instar larvae were grafted individually in plastic
queen starter cells (Nicoplast™) that had been sterilized
in 70% ethanol for 30min. The plastic cells were placed in
the cells of 48-well tissue culture plates, on top of a piece
of wet dental roll imbibed with 15.5% glycerol in 0.4%
methyl benzethonium chloride to prevent unwanted
microorganism growth. The larvae were reared in vitro,
according to standard methods [59]. In brief, the culture
plates were placed in a hermetic desiccator containing
a dish filled with saturated K2SO4 solution, which ensured
a relative humidity of 95% needed to prevent dehydration
of larvae. The desiccator containing the larvae was placed
into an incubator at 34.5°C for the first six days of larval
development. At day 7, when the larvae defecate and start
to pupate, the plates were moved into a desiccator con-
taining a dish filledwith saturatedNaCl solution to ensure
an optimal relative humidity of 75%. The larvae were fed
daily with pre-warmed diet (34.5°C), according to the
following feeding program: on the day of grafting, larvae
were provided with 10 µl of diet A (1.2 g glucose, 1.2 g
fructose, 0.2 g yeast extract and 8.4 g pure water, filter
sterilized (0.2 µm) and mixed with 10 g pure royal jelly).
On day 3, larvae were fed 20 µl of diet B (1.5 g glucose,
1.5 g fructose, 0.3 g yeast extract and 8 g pure water, filter
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sterilized (0.2 µm) and mixed with 10 g pure royal jelly).
On days 4, 5 and 6, larvae were fed with 30, 40 and 50 µl of
diet C, respectively. Diet C consisted of 1.8 g glucose, 1.8 g
fructose, 0.4 g yeast extract and 7.45 g pure water, filter
sterilized (0.2 µm) and mixed with 10 g pure royal jelly
[59,78]. The royal jelly was obtained from healthy colo-
nies and stored at −20°C.
For in vitro infection experiments, M. plutonius
isolates were cultivated in a liquid basal medium at
36°C under anaerobic conditions for four days. In
order to standardize the number of bacteria adminis-
tered in the infection assays, we determined the con-
centration of viable bacterial cells using colony
forming units (CFUs) counting. The CFUs from
a serial dilution spread on basal medium agar plates
were counted after four days of incubation at 36°C
under anaerobic conditions [76]. During this time
and before administration, bacterial cultures were
stored at 4°C.
Paenibacillus alvei type strain DSM29 was obtained
from the German Culture Collection (DSMZ,
Braunschweig, Germany) and cultivated on casein-
peptone agar plates under aerobic conditions at 30°C
for three weeks, until spores formed. Spores were har-
vested from agar plates by scraping them off the plate
and suspending them in saline (0.9% NaCl in distilled
water). The spores were washed once with saline,
diluted in saline and heat treated for 5 minutes at 90°
C. The total P. alvei spore concentration was deter-
mined via 10-fold dilutions plated on casein-peptone
agar plates and CFU counting [79]. Spore suspensions
were stored at 4°C.
Infection with M. plutonius was induced by admin-
istering a droplet of 10 µl diet A spiked with 107 CFU
ml−1 of the respective M. plutonius isolate
(1:9 M. plutonius inoculum-diet mix) on day 1, within
two hours of grafting. Hence, each larva was fed 105
CFU of M. plutonius. Larvae were infected with P. alvei
on day 1 by receiving 10 µl of diet A spiked with 105
spores of P. alvei per ml of saline (i.e. 103 P. alvei spores
per larva). Co-infections were performed by feeding
10 µl diet A spiked with a mix of 105 P. alvei DSM29
spores ml−1 and 107 CFU ml−1 of M. plutonius isolate
CH 90. This isolate was selected for co-infection assays
for its relatively low virulence, which facilitates the
detection of a putative increased mortality due to
P. alvei. Non-infected control larvae received 10 µl of
diet A mixed with sterile saline. We administered
a lower number of P. alvei spores per larva (103) than
in other studies (6 x 104; [42,47]). This lower dose is
closer to the one eliciting American foulbrood symp-
toms in infections by the congeneric bacteria P. larvae
(20 spores/larva; [80]), and comparable to the number
of P. alvei spores larvae were exposed to in a recent
study (8.3 x 103; [42]).
Honey bee larvae were subjected to single infections
with M. plutonius, single infections with P. alvei and co-
infections with M. plutonius and P. alvei. We monitored
brood survival and compared brood mortality caused by
the isolates, alone or in combination. The status of each
larva (dead or alive) was recorded every 24 h by observing
it under a microscope. Larvae or pupae without signs of
respiration or reaction to mechanical stimulus were
recorded as dead and removed from the plates [78]. In
contrast to other studies [34,41,42,46,47], we monitored
brood survival until completion of development (i.e. until
imaginal stage) to take into account the whole brood
developmental period to assess its mortality. For each
strain or combination of strains, 2–6 replicates were per-
formed, each with 24–84 larvae produced by 2–8 queens
(Tab. S2).
Growth dynamics of M. plutonius isolates
For each M. plutonius isolate used in the infections
assays (17 isolates), ten replicates (two runs with five
replicates each) of 20 ml liquid basal medium were
inoculated with a single M. plutonius colony pre-
cultured on an agar plate for three days and incubated
under anaerobic conditions at 36°C. Bacterial growth
was monitored by measuring optical density at 600 nm
(OD600) with a spectrophotometer (DR/2000, HACH),
every 6 h until 96 h past inoculation [81]. OD600 was
averaged over the ten replicates. Based on this data, we
calculated the generation time and compared the
growth dynamics of the isolates (see below).
Statistics
Survival differences in honey bee brood after experi-
mental infection with M. plutonius or P. alvei, or with
a combination of M. plutonius and P. alvei, were illu-
strated with Kaplan-Meier survival curves with 95%
confidence intervals [82]. Differences in survival
between hosts infected by various isolates, and between
the latter and uninfected controls were tested using
pairwise log-rank tests (Mantel-Haenszel test [83])
and adopting a significance level α of 0.05, corrected
by a Bonferroni-Holm procedure for multiple compar-
isons [84]. We calculated the Henderson-Tilton cor-
rected mortality rate of individuals dead until day 21
of development, when the imago stage is reached, as
follows: mortality ratio = 1- ((number of live test bees
after treatment * number of live control bees after
treatment-1) * (number of live control bees before treat-
ment * number of live bees before treatment-1)) [85],
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and state the resulting mortality rate caused by each
tested M. plutonius isolate in Table 1.
We used the R package growthrates [86] to compute
the growth constant k for each isolate, by fitting segments
of linear models to the log-transformed OD600 values
during the exponential growth phase [81]. The generation
time (g) of each isolate was then calculated [87] as g = ln
(2)/k. As recommended by Hall et al., 2013 [81], we
verified the fit to the exponential phase generated by the
algorithm implemented in Petzoldt, 2016 [86]. For isolate
CH 54.1, the algorithm did not identify the exponential
phase correctly, due to a long and irregular lag phase. We
obtained a corrected dataset by excluding the first six
points for this isolate well ahead of the exponential
phase, which led to correct fitting. The overall correlation
between growth rate andmortality, as well as the results of
the regression model, were similar between the corrected
dataset, the original dataset, and after excluding this iso-
late from the dataset (Tab. S7). We chose to present
conservative results of the regression model, based on
the dataset excluding CH 54.1.
Generation time only considers the exponential
phase of the bacterial growth cycle. To analyze the
growth dynamics over the entire experiment (96 h),
we used permutation tests with 100,000 iterations to
conduct pairwise comparisons between growth curves
[88,89]. These statistical analyses were done in R (R
Foundation for Statistical Computing, Vienna, Austria)
with the statmod package [90].
A multiple regression analysis [91] was conducted to
examine the relationship between the Henderson-
Tilton corrected mortality and the potential virulence
factors multi-locus sequence type, clonal complex, gen-
eration time, final density (density reached at 84 h) and
presence of melissotoxin A gene. For this model, we
used SPSS Statistics, version 21 (IBM Corp.).
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